TATAELXSI: Transportation-led growth (5–7%) depends on OEM spend; Media/Healthcare recovery vital for 8–10%+. EBITDA expansion (24–26%) hinges on utilization/cost discipline, but vertical concentration and cyclicality remain risks. Margins could reach 26–27% in bull case, tempered by Media/Healthcare execution and defense receivable challenges.
📊 Base Case (50% Probability)
Transportation grows mid-single digits, Media/Healthcare recover in Q4, and utilization hits 80%. EBITDA expands to 24–25% by FY27 on operating leverage. Defense/aerospace contributes 2–3% of revenue with neutral ROCE. Key variables: (1) Q4 deal wins, (2) hiring calibration. Outcome: Revenue growth 7–9% YoY; margins stabilize at 23–25%.
Continue reading “TATAELXSI – Q3 FY26 Earnings Call – 13-Jan-26”FY’27 Outlook: Base case projects 4–6% revenue growth, stable 21–22% margins, and 8–10% EPS rise, backed by tariff resolutions, AI scaling, and discretionary rebound. Bear case warns of <2% growth, 19–20% margins, and flat EPS if tariffs persist and AI lags. Bull case eyes 8%+ revenue, 23%+ margins, and 15%+ EPS via AI-driven surges and M&A.
📊 Base Case (50% Probability)